Home > Income Statement > ANTHEM BIOSCIENCES

ANTHEM BIOSCIENCES
Revenue

    Back to Income Statement
ANTHEM BIOSCIENCES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ANTHEM BIOSCIENCES
Please provide your vote to see the results

ANTHEM BIOSCIENCES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,124 Cr₹1,845 Cr₹1,419 Cr₹1,057 Cr₹1,231 Cr

What is the latest Revenue of ANTHEM BIOSCIENCES ?

The latest Revenue ratio of ANTHEM BIOSCIENCES is ₹2,124 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,124 Cr
Mar2025₹1,845 Cr
Mar2024₹1,419 Cr
Mar2023₹1,057 Cr
Mar2022₹1,231 Cr

How is Revenue of ANTHEM BIOSCIENCES Trending?

Years Revenue % Change
Mar2026 ₹2,124 Cr
15.17
Mar2025 ₹1,845 Cr
29.96
Mar2024 ₹1,419 Cr
34.29
Mar2023 ₹1,057 Cr
-14.16
Mar2022 ₹1,231 Cr -

Compare Revenue of peers of ANTHEM BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANTHEM BIOSCIENCES ₹42,102.9 Cr -2.6% -4.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,644.0 Cr 1.1% 7.2% 15.4% Stock Analytics
DIVIS LABORATORIES ₹184,053.0 Cr 2.4% 4.2% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹167,464.0 Cr 1.9% 8.3% 45.6% Stock Analytics
CIPLA ₹115,263.0 Cr -1.8% 3.2% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -8.8% -3.2% -4.6% Stock Analytics


ANTHEM BIOSCIENCES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ANTHEM BIOSCIENCES

-2.6%

-4.2%

NA
SENSEX

-0.9%

4.9%

-6.8%


You may also like the below Video Courses